Conference Track

Mother-to-Child Transmission and Management Issues in Resource-Poor Settings

Source: CCO Independent Conference Coverage of the 2005 International AIDS Society Conference on HIV Pathogenesis and Treatment*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Capsule Summaries

Significant Reduction in Mortality in South African Workers Six Months After Starting HAART in Workplace Program
Short-Course Zidovudine/Lamivudine Reduces Risk of Emergent Maternal and Infant Resistance Mutations Following Single-Dose Nevirapine Prophylaxis
Cameroon Expands Prevention of Mother-to-Child Transmission (PMTCT) Services to 80% of Health Districts
Male Partner Counseling and Testing Feasible Within Rural Indian Antenatal Program
Circumcision Significantly Reduces HIV Transmission in South African Males
Lamivudine Prophylaxis During Breastfeeding Period Reduces Infant HIV Infection Rate at 6 Months
Adverse Pregnancy Outcomes More Common in HIV-Infected Women in Rural South Africa
Virologic Efficacy and Emergent Resistance Mutations in African Patients With Advanced HIV Disease Receiving a Triple-NRTI Regimen
No Observed Increase in Complications in South African Patients Initiating Nevirapine-Based HAART With Concomitant Rifampin

Expert Analysis

Mother-to-Child Transmission and Management Issues in Resource-Limited Settings

Program Director: John P. Phair, MD

Faculty:

Michel Kazatchkine, MD
James McIntyre, MD
Charles van der Horst, MD

Learning Objectives

Upon completion of this activity, participants should be able to:

Explain other preventative measures for HIV transmission, such as counseling of male partners of HIV-positive women and circumcision of HIV-negative males.
List results of studies involving combinations of antiretroviral agents and tuberculosis (TB) therapy.
Recount results from HIV prevention programs in developing countries.
Describe the role of antiretroviral agents in the prevention of perinatal HIV-1 transmission from mother to infant.
Discuss the effect of perinatal antiretroviral treatment on subsequent response to antiretroviral therapy in HIV-positive women.

CME CREDIT INFORMATION

Release Date: 09/30/05

Expiration Date: 09/29/06

Physicians: maximum of 1.5 AMA PRA Category 1 Credits™

Registered Nurses: 1.7 Nursing CE credits

Pharmacists: 1.4 contact hours (0.14 CEUs)

Status: Please log in to view status

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.